Twenty one pioneering research projects to boost dementia diagnosis rates and trial ground breaking treatments have been selected to receive a share of £22million NIHR funding, Health Secretary Jeremy Hunt announced today.

Visiting pharmaceutical company Eli Lilly’s UK dementia research centre, the Health Secretary emphasised the crucial role of medical research in making breakthroughs in the prevention and treatment of dementia, whilst ensuring that research can help people with dementia live well with the condition today.

The funding awarded by the NIHR covers all areas of scientific activity relevant to dementia, across the fields of care, cure and cause, including prevention.